Company Summary

Eulysis' mission is to optimize pharmaceutical delivery through novel packaging innovations. Our groundbreaking technology is the only one capable of delivering lyophilized pharmaceuticals within a single, easy-to-use container. Applications include vaccines, cancer treatments, antibiotics and antidotes. Optimizes the entire supply chain while reducing contamination risks, simplifying administration and saving more patient lives at point of use.

Team

Spyridon Tsakas

Mr.

Spyridon "Ross" Tsakas is an innovative, multi-award winning entrepreneur with diverse Start-Up, Product and Market Development experience. He is the Founder & President of Eulysis Group based at the Roslin Biocentre in Scotland, specialising in Personal Health Care and Pharmaceuticals. His current project titled the Single Vial System involves a unique manufacture and reconstitution technology for pharmaceuticals.

Some of his more prominent

Grahame Bulfield

Professor

Grahame Bulfield CBE is an Emeritus Professor of Genetics at the University of Edinburgh and a Consultant in Biotechnology. From 2002 to 2008 he was Vice Principal and Head of the College of Science and Engineering at the University of Edinburgh, and is a former Director of the Roslin Institute.
Professor Bulfield was appointed an Honorary Professor of the University of Edinburgh in 1990, to a Personal Chair of Animal Genetics in 2002 and electe

Malcolm Bateman

Mr.

A Chartered Management Accountant, who has extensive operational and general management experience. Worked for UK, US and German automotive and pharmaceutical multinationals both in the UK and overseas. More recently involved with a world renowned research establishment, university commercialisation initiatives, science park management and early stage life science companies. Comprehensive board experience with directorships in private, public and